FTC's Ohlhausen Sees Light At End Of Pay-For-Delay Tunnel

The Federal Trade Commission may have "finally started to turn the corner" with its crackdown on pay-for-delay patent settlements, but other efforts by branded-drug makers to stave off generic competition have...

Already a subscriber? Click here to view full article